Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic

NCT04480060 | Completed

• 1 other identifier: KSSEAH--EDCC
• Study Type: observational
• Target: 100,000
• Locations: 1 country
• Sites: 1

Brief Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Emergency departments also carried out an important part of the fight against pandemics in our country/Turkey. The emergency department including an intensive care unit is very few in this country/Turkey and the only hospital, which has an Emergency Intensive Care Unit (EICU) in Istanbul, is the study center. Therefore, this retrospective study aimed to provide useful information about how an effective EICU should be, especially how to use them during pandemic periods.

Conditions

Covid19

Outcome Measures

Primary Outcomes (1)

• Mortality of the COVID-19 patients

  Mortality of the COVID-19 patients who followed up by emergency department ICU

  3 months

Interventions

COVID-19 diagnostic PCR DIAGNOSTIC_TEST

Nasopharyngeal swab samples will be analyzed by PCR for COVID-19 DNA existence.

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

All patients who followed up in emergency department ICU's of study centers with the diagnosis of COVID-19

You may qualify if:

• All patients who followed up in emergency department ICU with the diagnosis of COVID-19
• Accepted to participate with an informed consent

You may not qualify if:

• Patients under the age of 18 or more than 50 years
• declined to participate
• deaths caused by other than COVID-19

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Seda Yilmaz Semerci

Istanbul, 34303, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: July 18, 2020
• First Posted: July 21, 2020
• Study Start: March 10, 2020
• Primary Completion: June 30, 2020
• Study Completion: July 14, 2020
• Last Updated: July 21, 2020

Record last verified: 2020-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)